Stifel Maintains Buy on 10x Genomics, Raises Price Target to $68
Benzinga Newsdesk 15 hours ago
Analyst RatingsNewsPrice Target
Stifel analyst Daniel Arias maintains 10x Genomics (NASDAQ:TXG) with a Buy and raises the price target from $50 to $68.
Stifel analyst Daniel Arias maintains 10x Genomics (NASDAQ:TXG) with a Buy and raises the price target from $50 to $68.